Barzolvolimab Improves Urticaria Control and Quality of Life in Patients with Chronic Spontaneous Urticaria: 52-Week Data

被引：0

作者：

Maurer, Marcus ^{[1
]}

Metz, Martin ^{[1
]}

Kobielusz-Gembala, Iwona ^{[2
]}

Mitha, Essack ^{[3
]}

Leflein, Jeffrey ^{[4
]}

Gotua, Maia ^{[5
]}

Fuentes-Duculan, Judilyn ^{[6
]}

Paradise, Elsa ^{[6
]}

Ma, Rick ^{[6
]}

Green-berg, Steven ^{[6
]}

Young, Diane ^{[6
]}

Bernstein, Jonathan ^{[7
,8
]}

机构：

[1] Charite, Berlin, Germany

[2] Medicome Sp Zoo, Oswiecim, Poland

[3] Newtown Clin Res, Johannesburg, South Africa

[4] Resp Med Res Inst Michigan, Ypsilanti, MI USA

[5] Ctr Allergy & Immunol, Tbilisi, Georgia

[6] Celldex Therapeut, Hampton, NJ USA

[7] Univ Cincinnati, Coll Med, Cincinnati, OH USA

[8] Bernstein Allergy Grp, Cincinnati, OH USA

来源：

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2025年 / 155卷 / 02期

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

L11

引用

页码：AB431 / AB431

页数：1

共 50 条

[21] The impact of omalizumab on quality of life and its predictors in patients with chronic spontaneous urticaria: Real-life data
Salman, Andac
Demir, Gizem
Bekiroglu, Nural
DERMATOLOGIC THERAPY, 2019, 32 (04)
[22] Quality of Life, Disease Burden and subjective Symptoms of Patients with chronic spontaneous Urticaria
Langenbruch, A.
Kressel, N.
Braun, V
Maurer, M.
Reich, K.
Augustin, M.
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2017, 15 : 113 - 114
[23] Factors associated with quality of life of chronic spontaneous urticaria patients in a Vietnamese population
Nguyen Thi Tra My
Le Huyen My
Vu Nguyet Minh
Nguyen Thi Ha Vinh
Mai Ba Hoang Anh
Doanh Le Huu
PLOS ONE, 2025, 20 (01):
[24] Chronic Spontaneous Urticaria: How to Assess Quality of Life in Patients Receiving Treatment
Weller, Karsten
Church, Martin K.
Kalogeromitros, Dimitrios
Krause, Karoline
Magerl, Markus
Metz, Martin
Pisarevskaja, Dina
Siebenhaar, Frank
Maurer, Marcus
ARCHIVES OF DERMATOLOGY, 2011, 147 (10) : 1221 - 1223
[25] Barzolvolimab demonstrates clinical activity in a multiple ascending dose trial in chronic spontaneous urticaria
Maurer, M.
Metz, M.
Anderson, J.
Talreja, N.
Windom, H.
Alvarado, D.
Crowley, E.
Young, D.
Merchant, K.
Hawthorne, T.
Paradise, E.
Heath-Chiozzi, M.
Bernstein, J.
ALLERGY, 2023, 78 : 220 - 221
[26] Montelucast in the treatment of chronic spontaneous urticaria: management and quality of life
Davidouskaya, A. L.
Ruzanau, D. Y.
ALLERGY, 2015, 70 : 597 - 597
[27] Headache deteriorates the quality of life in children with chronic spontaneous urticaria
Filiz, S.
Kutluk, M. G.
Uygun, D. F. K.
ALLERGOLOGIA ET IMMUNOPATHOLOGIA, 2019, 47 (03) : 254 - 259
[28] Disease control and quality of life in chronic spontaneous urticaria and recurrent angioedema are strongly linked, but not in all patients
Neisinger, Sophia
Salameh, Pascale
Gutsche, Annika
Aulenbacher, Felix
Siebenhaar, Frank
Maurer, Marcus
CLINICAL AND TRANSLATIONAL ALLERGY, 2025, 15 (01)
[29] The Frequency of Chronic Widespread Pain and Its Impact on Quality of Life in Patients with Chronic Spontaneous Urticaria
Ertas, Ragip
Erol, Kemal
KONURALP TIP DERGISI, 2019, 11 (01): : 101 - 105
[30] Safety and Clinical Activity of Multiple Doses of Barzolvolimab, an anti-KIT Antibody, in Patients with Chronic Spontaneous Urticaria
Maurer, Marcus
Metz, Martin
Anderson, John
Talreja, Neetu
Windom, Hugh
Alvarado, Diego
Crowley, Elizabeth
Young, Diane
Merchant, Kunal
Paradise, Elsa
Heath-Chiozzi, Margo
Bernstein, Jonathan
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (02) : AB133 - AB133

← 1 2 3 4 5 →